Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ivermectin
Therapeutic Area : Dermatology
Study Phase : Phase III
Recipient : Zydus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Ivermectin Cream 1% in Treatment of Moderate to Severe Facial Rosacea
Details : Ivermectin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Rosacea.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 27, 2019
Lead Product(s) : Ivermectin
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Recipient : Zydus Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adapalene
Therapeutic Area : Dermatology
Study Phase : Phase III
Recipient : Aleor Dermaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
Details : Adapalene is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Acne Vulgaris.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 28, 2018
Lead Product(s) : Adapalene
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Recipient : Aleor Dermaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
